NEJAT JALISI: Open Payments
NPI 1063651552 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,976 in 124 payments from 29 companies in 2025. Trend: 2023 $997 · 2024 $2,367 · 2025 $2,976
Food & beverage: $2,976
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $303 |
| Novo Nordisk Inc | 13 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $245 |
| PFIZER INC. | 11 | $227 |
| Amgen Inc. | 6 | $206 |
| Insulet Corporation | 3 | $206 |
| ABBVIE INC. | 15 | $195 |
| Kowa Pharmaceuticals America, Inc. | 9 | $172 |
| Corcept Therapeutics | 7 | $171 |
| Xeris Pharmaceuticals, Inc. | 8 | $166 |
Products named: Auvelity, Kerendia, OMNIPOD, ZORYVE, Korlym, Wegovy, REPATHA, UBRELVY.
Industry payments across CA — which companies pay providers there.
